Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,490
Closed -$269K 307
2024
Q1
$269K Sell
10,490
-589
-5% -$14.8K 0.03% 272
2023
Q4
$289K Sell
11,079
-372
-3% -$8.49K 0.03% 265
2023
Q3
$264K Sell
11,451
-57
-0.5% -$1.43K 0.03% 252
2023
Q2
$270K Buy
11,508
+288
+3% +$4.89K 0.03% 257
2023
Q1
$133K Sell
11,220
-31
-0.3% -$442 0.02% 273
2022
Q4
$173K Sell
11,251
-859
-7% -$15K 0.02% 272
2022
Q3
$230K Buy
12,110
+412
+4% +$8.18K 0.04% 251
2022
Q2
$210K Buy
11,698
+1,421
+14% +$32.7K 0.03% 277
2022
Q1
$309K Buy
+10,277
New +$321K 0.04% 267

Other funds holding XP

Marks Group Wealth Management's XP Position: Q2 2024 in Review

Marks Group Wealth Management sold out of XP (XP) in Q2 2024, closing a stake of 10,490 shares — an estimated $269K sold.

Marks Group Wealth Management first reported a position in XP in Q1 2022 and held it in 9 quarters. The position peaked at $309K in Q1 2022. 265 funds tracked by Wall St. Rank hold XP as of Q2 2024.

  • Marks Group Wealth Management reported no remaining XP position as of Q2 2024 after selling out during the quarter.
  • Marks Group Wealth Management sold 10,490 XP shares in Q2 2024, an estimated $269K.
  • Marks Group Wealth Management first reported a position in XP in Q1 2022 and held it in 9 quarters.
  • Marks Group Wealth Management's XP position peaked at $309K in Q1 2022.
  • 265 funds tracked by Wall St. Rank held XP as of Q2 2024.

Based on Marks Group Wealth Management's 13F filing for Q2 2024, filed 14 Aug 2024.